Evidence map›Paper›PMID 39683750›Full record

ReviewMolecules (Basel, Switzerland)2024

Manganese Oxide Nanoparticles for MRI-Based Multimodal Imaging and Theranostics.

Carlos F G C Geraldes

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. [Study of the Correlation Between MRI Parameters, Microvascular Density, and Prognosis in Glioma].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Article
  3. Article
  4. Iron-Based Nanoparticles as Delivery Tools.Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Carlos F G C GeraldesDepartment of Life Sciences and Coimbra Chemistry Center-Institute of Molecular Sciences (CQC-IMS), Faculty of Science and Technology, University of Coimbra, 3004-531 Coimbra, Portugal.ORCID 0000-0002-0837-8329

Funding

FUNDAÇÃO PARA A CIÊNCIA E TECNOLOGIA (FCT-PORTUGAL) UIDB/00313/2020FUNDAÇÃO PARA A CIÊNCIA E TECNOLOGIA (FCT-PORTUGAL) UIDP/00313/2020
6 · The paper itself

Abstract

Manganese-based MRI contrast agents have recently attracted much attention as an alternative to Gd-based compounds. Various nanostructures have been proposed for potential applications in in vivo diagnostics and theranostics. This review is focused on the discussion of different types of Mn oxide-based nanoparticles (Mn

Indexed as

Manganese CompoundsMultimodal ImagingOxidesTheranostic NanomedicineAnimalsContrast MediaHumansMagnetic Resonance ImagingMetal NanoparticlesNanoparticlesContrast MediaManganese Compoundsmanganese oxideOxidescontrast agentsfunctionalized nanoparticlesmagnetic resonance imagingmanganese oxidesmultimodal imagingtheranostics

Identifiers

PMID39683750
PMCPMC11643175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.